BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

422 related articles for article (PubMed ID: 20236684)

  • 21. Younger women with breast carcinoma have a poorer prognosis than older women.
    Chung M; Chang HR; Bland KI; Wanebo HJ
    Cancer; 1996 Jan; 77(1):97-103. PubMed ID: 8630946
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular classification system identifies invasive breast carcinoma patients who are most likely and those who are least likely to achieve a complete pathologic response after neoadjuvant chemotherapy.
    Goldstein NS; Decker D; Severson D; Schell S; Vicini F; Margolis J; Dekhne NS
    Cancer; 2007 Oct; 110(8):1687-96. PubMed ID: 17722109
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Survival analysis between patients with invasive ductal and invasive lobular breast cancer.
    Dian D; Herold H; Mylonas I; Scholz C; Janni W; Sommer H; Friese K
    Arch Gynecol Obstet; 2009 Jan; 279(1):23-8. PubMed ID: 18449551
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinicopathologic characteristics of 143 patients with synchronous bilateral invasive breast carcinomas treated in a single institution.
    Intra M; Rotmensz N; Viale G; Mariani L; Bonanni B; Mastropasqua MG; Galimberti V; Gennari R; Veronesi P; Colleoni M; Tousimis E; Galli A; Goldhirsch A; Veronesi U
    Cancer; 2004 Sep; 101(5):905-12. PubMed ID: 15329896
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metaplastic breast carcinoma: pathology and clinical outcome.
    Bellino R; Arisio R; D'Addato F; Attini R; Durando A; Danese S; Bertone E; Grio R; Massobrio M
    Anticancer Res; 2003; 23(1B):669-73. PubMed ID: 12680165
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Grading system for lymph vessel tumor emboli: significant outcome predictor for invasive ductal carcinoma of the breast.
    Hasebe T; Okada N; Iwasaki M; Akashi-Tanaka S; Hojo T; Shibata T; Sasajima Y; Tsuda H; Kinoshita T
    Hum Pathol; 2010 May; 41(5):706-15. PubMed ID: 20060154
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Challenges and potential pitfalls in magnetic resonance imaging of more elusive breast carcinomas.
    Le-Petross H; Lane D
    Semin Ultrasound CT MR; 2011 Aug; 32(4):342-50. PubMed ID: 21782124
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Atypical tumor-stromal fibroblasts in invasive ductal carcinoma of the breast.
    Hasebe T; Iwasaki M; Akashi-Tanaka S; Hojo T; Shibata T; Sasajima Y; Kinoshita T; Tsuda H
    Am J Surg Pathol; 2011 Mar; 35(3):325-36. PubMed ID: 21317705
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nomogram for the prediction of having four or more involved nodes for sentinel lymph node-positive breast cancer.
    Katz A; Smith BL; Golshan M; Niemierko A; Kobayashi W; Raad RA; Kelada A; Rizk L; Wong JS; Bellon JR; Gadd M; Specht M; Taghian AG
    J Clin Oncol; 2008 May; 26(13):2093-8. PubMed ID: 18445838
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic significance of molecular classification of breast invasive ductal carcinoma.
    Muñoz M; Fernández-Aceñero MJ; Martín S; Schneider J
    Arch Gynecol Obstet; 2009 Jul; 280(1):43-8. PubMed ID: 19082617
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Carcinoma in situ of the female breast. A clinico-pathological, immunohistological, and DNA ploidy study.
    Ottesen GL
    APMIS Suppl; 2003; (108):1-67. PubMed ID: 12874968
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stromelysin 3: an independent prognostic factor for relapse-free survival in node-positive breast cancer and demonstration of novel breast carcinoma cell expression.
    Ahmad A; Hanby A; Dublin E; Poulsom R; Smith P; Barnes D; Rubens R; Anglard P; Hart I
    Am J Pathol; 1998 Mar; 152(3):721-8. PubMed ID: 9502414
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Histopathologic factors significantly associated with initial organ-specific metastasis by invasive ductal carcinoma of the breast: a prospective study.
    Hasebe T; Imoto S; Yokose T; Ishii G; Iwasaki M; Wada N
    Hum Pathol; 2008 May; 39(5):681-93. PubMed ID: 18329692
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Invasive node-negative breast carcinoma: multivariate analysis of the prognostic value of peritumoral vessel invasion compared with that of conventional clinico-pathologic features.
    Barbareschi M; Dalla Palma P; Bevilacqua P; Maluta S; Caffo O; Meli S; Boracchi P; Gasparini G
    Anticancer Res; 1994; 14(5B):2229-35. PubMed ID: 7840528
    [TBL] [Abstract][Full Text] [Related]  

  • 35. B7-h4 is highly expressed in ductal and lobular breast cancer.
    Tringler B; Zhuo S; Pilkington G; Torkko KC; Singh M; Lucia MS; Heinz DE; Papkoff J; Shroyer KR
    Clin Cancer Res; 2005 Mar; 11(5):1842-8. PubMed ID: 15756008
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Unique clinicopathological features of metaplastic breast carcinoma compared with invasive ductal carcinoma and poor prognostic indicators.
    Song Y; Liu X; Zhang G; Song H; Ren Y; He X; Wang Y; Zhang J; Zhang Y; Sun S; Liang X; Sun Q; Pang D
    World J Surg Oncol; 2013 Jun; 11():129. PubMed ID: 23738706
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential expression of E-cadherin in lobular and ductal neoplasms of the breast and its biologic and diagnostic implications.
    Acs G; Lawton TJ; Rebbeck TR; LiVolsi VA; Zhang PJ
    Am J Clin Pathol; 2001 Jan; 115(1):85-98. PubMed ID: 11190811
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic significance of mitotic figures in metastatic mammary ductal carcinoma to the lymph nodes.
    Hasebe T; Iwasaki M; Akashi-Tanaka S; Hojo T; Shibata T; Sasajima Y; Kinoshita T; Tsuda H
    Hum Pathol; 2011 Dec; 42(12):1823-32. PubMed ID: 21683981
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The prognosis of tumors with only microscopic skin involvement without clinical T4b signs is significantly better than T4b tumors in breast carcinoma.
    Duraker N; Batı B; Caynak ZC; Demir D; Kurtuluş I
    Breast J; 2011; 17(1):47-55. PubMed ID: 21129094
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of triple-negative and estrogen receptor-positive/progesterone receptor-positive/HER2-negative breast carcinoma using quantitative fluorine-18 fluorodeoxyglucose/positron emission tomography imaging parameters: a potentially useful method for disease characterization.
    Basu S; Chen W; Tchou J; Mavi A; Cermik T; Czerniecki B; Schnall M; Alavi A
    Cancer; 2008 Mar; 112(5):995-1000. PubMed ID: 18098228
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.